UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Leukemia, 2013-06, Vol.27 (6), p.1229-1235

2013

Volltextzugriff (PDF)

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Leukemia, 2017-10, Vol.31 (10), p.2161-2171

2017

Volltextzugriff (PDF)

MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease

Gut, 2010-08, Vol.59 (8), p.1079-1087

2010

Volltextzugriff (PDF)

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control

Oncoimmunology, 2016-04, Vol.5 (4), p.e1115178-e1115178

2016

Volltextzugriff (PDF)

Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion

International journal of hematology, 2010-06, Vol.91 (5), p.877-885

2010

Volltextzugriff (PDF)

Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

Leukemia, 2013-09, Vol.27 (9), p.1910-1913

2013

Volltextzugriff (PDF)

Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy

American journal of transplantation, 2009-07, Vol.9 (7), p.1679-1684

2009

Volltextzugriff (PDF)

Use of natural killer cells in hematopoetic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-04, Vol.35 (7), p.637-643

2005

Volltextzugriff (PDF)

CD56 CD16 cells are responsible for natural cytotoxicity against tumor targets

Leukemia, 2005-05, Vol.19 (5)

2005

Volltextzugriff (PDF)

Validation of leukapheresis procedure and extended release testing for manufacturing of ATMPs

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S83-S84

2017

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

Bone marrow transplantation (Basingstoke), 2012-09, Vol.47 (9), p.1171-1177

2012

Volltextzugriff (PDF)

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)

Journal of cancer research and clinical oncology, 2016-01, Vol.142 (1), p.305-315

2016

Volltextzugriff (PDF)

Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy

Bone marrow transplantation (Basingstoke), 2009-01, Vol.43 (1), p.13-19

2009

Volltextzugriff (PDF)

Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis

Bone marrow transplantation (Basingstoke), 2009-08, Vol.44 (4), p.269-270

2009

Volltextzugriff (PDF)

Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-03, Vol.39 (5), p.293-299

2007

Volltextzugriff (PDF)

Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection

Medical microbiology and immunology, 2014-04, Vol.203 (2), p.115-123

2014

Volltextzugriff (PDF)

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

Medical microbiology and immunology, 2012-08, Vol.201 (3), p.277-286

2012

Volltextzugriff (PDF)

In vivo diagnosis of acute intestinal graft-versus-host disease by confocal endomicroscopy

Endoscopy, 2009-05, Vol.41 (5), p.433

2009

Volltextzugriff (PDF)

Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients

International journal of hematology, 2007-08, Vol.86 (2), p.158-162

2007

Volltextzugriff (PDF)

Reply to Dr Grzywacz

Leukemia, 2007-02, Vol.21 (2), p.359-359

2007

Volltextzugriff (PDF)

Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT

Bone marrow transplantation (Basingstoke), 2009-08, Vol.44 (3), p.185-192

2009

Volltextzugriff (PDF)

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (6), p.445-451

2006

Volltextzugriff (PDF)

Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma

Bone marrow transplantation (Basingstoke), 2007-04, Vol.39 (7), p.389-396

2007

Volltextzugriff (PDF)

P-210 Azacitidine and DLI as salvage therapy for MDS or AML relapse after allo-SCT induces long-term molecular remissions and increases Tregs

Leukemia research, 2013-05, Vol.37, p.S118-S118

2013

Volltextzugriff (PDF)

Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2008-02, Vol.41 (4), p.377-383

2008

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(3)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(73)
Science & Technology
(73)
Hematology
(55)
Humans
(48)
Biological And Medical Sciences
(47)
Medical Sciences
(44)
Oncology
(39)
Transplantation
(37)
Animals
(36)
Female
(33)
Immunology
(30)
Male
(30)
Transplantation, Homologous
(29)
Mice
(28)
Stem Cell Transplantation
(26)
Mice, Inbred Balb C
(22)
Middle Aged
(22)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(21)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(21)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control

Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion

Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy

Use of natural killer cells in hematopoetic stem cell transplantation

CD56 CD16 cells are responsible for natural cytotoxicity against tumor targets

Validation of leukapheresis procedure and extended release testing for manufacturing of ATMPs

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)

Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy

Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis

Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation

Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

In vivo diagnosis of acute intestinal graft-versus-host disease by confocal endomicroscopy

Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients

Reply to Dr Grzywacz

Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma

P-210 Azacitidine and DLI as salvage therapy for MDS or AML relapse after allo-SCT induces long-term molecular remissions and increases Tregs

Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation

Suchergebnisse filtern